SCHEMBL12806101

SCHEMBL12806101

Cc1ccc2o[nH]c2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7053264 0.86 — —
SCHEMBL13304413 0.70 LMNA (0.43) —
SCHEMBL14644667 0.70 DAO (0.53) —
SCHEMBL14644670 0.66 ALDH1A1 (0.47) —
SCHEMBL1100359 0.66 DAO (0.61) —
SCHEMBL29490188 0.66 NOS1 (1.00) —
SCHEMBL243203 0.66 NOS1 (1.00) —
SCHEMBL31389041 0.66 PSMB8 (0.72) —
SCHEMBL18936106 0.64 ALDH1A1 (0.52) —
SCHEMBL6318703 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2308854-A1 2,3,6-trisubstituted-4-pyrimidone derivatives Sanofi-Aventis (FR) 2011-04-13 — — EP disclosed
EP-2305651-A1 2,3,6-trisubstituted-4-pyrimidone derivatives Mitsubishi Tanabe Pharma Corporation (JP) 2011-04-06 — — EP disclosed
Send feedback